Balentine LLC’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Balentine LLC’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-31	Closed	-$2K	–	476
2016 Q1	$2K	Hold	31	–	–	﹤0.01%	322
2015 Q4	$4K	Buy	31 +7	+29%	+$771	﹤0.01%	393
2015 Q3	$3K	Buy	+24	New	+$3.13K	﹤0.01%	438

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Balentine LLC's ANAC Position: Q2 2016 in Review

Balentine LLC sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 31 shares — an estimated $2K sold.

Balentine LLC first reported a position in ANAC in Q3 2015 and held it in 3 quarters. The position peaked at $4K in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Balentine LLC reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Balentine LLC sold 31 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $2K.
Balentine LLC first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2015 and held it in 3 quarters.
Balentine LLC's ANACOR PHARMACEUTICALS INC COM position peaked at $4K in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Balentine LLC's 13F filing for Q2 2016, filed 16 Aug 2016.